Cambridge Investment Research Advisors
TWST icon

Cambridge Investment Research Advisors’s Twist Bioscience TWST Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,236
Closed -$483K – 4075
2025
Q4 		$483K Buy
+15,236
New +$475K ﹤0.01% 2747

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cambridge Investment Research Advisors's TWST Position: Q1 2026 in Review

Cambridge Investment Research Advisors sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 15,236 shares — an estimated $483K sold.

Cambridge Investment Research Advisors first reported a position in TWST in Q4 2025 and held it in 1 quarter. The position peaked at $483K in Q4 2025. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Cambridge Investment Research Advisors reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15,236 Twist Bioscience shares in Q1 2026, an estimated $483K.
  • Cambridge Investment Research Advisors first reported a position in Twist Bioscience in Q4 2025 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Twist Bioscience position peaked at $483K in Q4 2025.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.